Institutions / Adage Capital Partners Gp, L.L.C.
Adage Capital Partners Gp, L.L.C.
CIK 1165408 · Institution · as of Mar 31, 2026
Portfolio value
$63.99B
Positions
953
As of
Mar 31, 2026
Portfolio trend
Portfolio value
$63.99B-1.9%Positions
953+5.5%Top holdings
Mar 31, 2026View all 953 →
| Company | Value | % of portfolio |
|---|---|---|
| NVIDIA Corp | $3.85B | 6.0% |
| Apple Inc. | $3.31B | 5.2% |
| Microsoft Corp | $2.43B | 3.8% |
| Amazon.com Inc | $1.91B | 3.0% |
| Alphabet Inc. | $1.50B | 2.3% |
| Broadcom Inc. | $1.27B | 2.0% |
| Meta Platforms Inc | $1.18B | 1.8% |
| Alphabet Inc. | $1.18B | 1.8% |
| Tesla Inc | $897.59M | 1.4% |
| ELI LILLY & Co | $880.05M | 1.4% |
| ConocoPhillips | $794.53M | 1.2% |
| JPMORGAN CHASE & CO | $710.47M | 1.1% |
| Johnson & Johnson | $602.06M | 0.9% |
| Revolution Medicines, Inc. | $532.50M | 0.8% |
| Chevron Corp | $517.41M | 0.8% |
| Walmart Inc. | $455.12M | 0.7% |
| Visa Inc | $450.05M | 0.7% |
| PROCTER & GAMBLE Co | $406.88M | 0.6% |
| Costco Wholesale Corp /New | $396.26M | 0.6% |
| Exxon Mobil Corp | $376.46M | 0.6% |
| Micron Technology Inc | $373.52M | 0.6% |
| Royalty Pharma PLC | $358.85M | 0.6% |
| Mastercard Inc | $356.56M | 0.6% |
| Centessa Pharmaceuticals PLC | $354.50M | 0.6% |
| Roivant Sciences Ltd. | $354.40M | 0.6% |
Activity
Mar 31, 2026View full history →
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2026 as of | Add | Revolution Medicines, Inc. | $318.01M | +3.3M +148.26% | 5,475,611 0.83% of portfolio | high |
| Q1 2026 as of | Add | Coterra Energy Inc. | $250.27M | +7.1M +648.99% | 8,219,512 0.45% of portfolio | high |
| Q1 2026 as of | Trim | G7709Q104 | $-204.35M | -4.3M -36.28% | 7,480,633 0.56% of portfolio | high |
| Q1 2026 as of | Exit | Avidity Biosciences, Inc. | $-189.77M | -2.6M -100.00% | — | high |
| Q1 2026 as of | Trim | Devon Energy Corp | $-181.91M | -3.6M -81.12% | 841,194 0.07% of portfolio | high |
| Q1 2026 as of | Trim | Terns Pharmaceuticals, Inc. | $-180.58M | -3.4M -61.72% | 2,124,817 0.18% of portfolio | high |
| Q1 2026 as of | Trim | DOVER Corp | $-173.94M | -834K -53.62% | 721,646 0.24% of portfolio | high |
| Q1 2026 as of | Add | RB Global Inc | $165.49M | +1.7M +323.55% | 2,260,145 0.34% of portfolio | high |
| Q1 2026 as of | Add | Boston Scientific Corp | $160.07M | +2.6M +122.50% | 4,633,237 0.45% of portfolio | high |
| Q1 2026 as of | Add | Chevron Corp | $149.09M | +721K +40.48% | 2,500,766 0.81% of portfolio | high |